Percutaneous Coronary Intervention

In a new analysis of the pooled cohort of the two STOPDAPT-2 trials of patients who had PCI, clopidogrel monotherapy after 1 month of dual antiplatelet therapy was associated with reduced bleeding risk regardless of diabetes status.

The shrunken pore syndrome phenotype of renal dysfunction after PCI may be a stronger predictor of contrast-induced acute kidney injury compared with chronic kidney disease, researchers reported.

Real-world data suggest intravascular lithotripsy appears to be safe with low complications rates during nearly 2 years of follow-up when used for complex calcified coronary lesions, researchers reported.

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March 4-6, 2023 in New Orleans and online.

Data from a meta-analysis show no difference in fluoroscopy time between transradial vs. transfemoral access for PCI; however, diagnostic coronary angiography continues to marginally favor transfemoral access, researchers reported.

Adults with severe obesity and underweight who underwent invasive coronary angiography procedures were more likely to die of any cause during follow-up compared with patients with normal weight, researchers reported.

Treatment effect of the PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) vs. sham control on LDL in patients with STEMI referred for primary PCI.

CHICAGO — In patients who had PCI with a drug-eluting stent, dual antiplatelet therapy with indobufen plus clopidogrel was noninferior to DAPT with aspirin plus clopidogrel, according to the results of the OPTION trial.

CHICAGO — In patients with STEMI undergoing primary PCI, mostly with radial artery access, anticoagulation with bivalirudin reduced death and major bleeding at 30 days compared with heparin, according to the results of the BRIGHT-4 trial.

CHICAGO — In this Healio exclusive, B. Hadley Wilson, MD, FACC, provides his perspective on several late-breaking clinical trials presented at the American Heart Association Scientific Sessions.